Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: Comparison with the second generation human TRAb assay

Clinica Chimica Acta

Volumn 407, Issue 1-2, 2009, Pages 62-66

  Massart, C ^a,b   Gibassier, J ^a   d'Herbomez, M ^c,d  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIV LILLE   (France)

Author keywords

Human radioreceptor assay; M22 antibody, Graves' disease; Prognostic value; TSH receptor antibody

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; LIOTHYRONINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M22; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIORECEPTOR ASSAY; REFERENCE VALUE; RELAPSE; REMISSION; TREATMENT DURATION;

EID: 67651102868     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.06.033     Document Type: Article

References (27)

1. Smith B.R., McLachlan S.M., and Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 9 (1988) 106-121
2. Weetman A., and McGregor A.M. Autoimmune thyroid disease: future developments in our understanding. Endocr Rev 15 (1994) 788-830
3. Filetti S., Foti D., Costante G., and Rapoport T. Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab 72 (1991) 1096-1101
4. Costagliola S., Morgenthaler N.G., Hoermann R., et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84 (1999) 90-97
5. Sanders J., Evans M., Premawardhana L.D.K.E., et al. Human monoclonal thyroid stimulating antibody. Lancet 362 (2003) 126-127
6. Kamijo K., Ishikawa K., and Tanaka M. Clinical evaluation of 3 rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr J 52 (2005) 525-529
7. Kamijo K. TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J 54 (2007) 619-624
8. Massart C., Sapin R., Gibassier J., Agin A., and d'Herbomez M. Inter-method variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves' disease and for the follow-up of Graves' ophthalmopathy. Clin Chem 55 (2009) 183-186
9. Ajjan R.A., and Weetman A.P. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 4 (2008) 461-468
10. Noh J.Y., Miyazaki N., Ito K., et al. Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid (2008) 1157-1164
11. Rees Smith B., Bolton J., Young S., et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 14 (2004) 830-835
12. Hermsen D., Broecker-Preuss M., Casati M., et al. Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. Clin Chim Acta 401 (2009) 84-89
13. Schott M, Hermsen D, Broecker-Preuss M, et al. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease: an international multicentre trial. Clin Endocrinol in press. Doi:10.1111/j.1365-2265.2008.03512.x.
14. Davies T.F., Roti E., Braverman E., and DeGroot L.J. Thyroid controversy-stimulating antibodies. J Clin Endocrinol Metab 83 (1998) 3777-3785
15. Feldt-Rasmussen U., Schleusener H., and Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 78 (1994) 98-102
16. Zimmermann-Belsing T., Nygaard B., Rasmussen A.K., and Feldt-Rasmussen U. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. Eur J Endocrinol 146 (2002) 173-177
17. Schott M., Morgenthaler N.G., Fritzen R., et al. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res 36 (2004) 92-96
18. Quadbeck B., Hoermann R., Roggenbuck U., et al. Sensitive thyrotropin-receptor antibody determinations one month after discontinuation drug treatment as predictors of relapse in Graves' disease. Thyroid 15 (2005) 1047-1054
19. Zöphel K., von Landenberg P., and Roggenbuck D. M22 based (manual) ELISA for TSH-receptor antibody (TRAb) measurement is more sensitive than 2nd generation TRAb assays. Clin Chim Acta 403 (2009) 266
20. Maugendre D., and Massart C. Clinical value of human TSH receptor binding antibody determination in the follow-up of anti-thyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody assay. Clin Endocrinol 54 (2001) 89-96
21. Passing H., and Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 21 (1983) 709-720
22. Zweig M.H., and Campbell G. Receiver-operating-characteristic ROC plots: a fundamental evaluation tool in clinical medecine. Clin Chem 39 (1993) 561-577
23. Carella C., Mazziotti G., Sorvillo F., et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid 16 (2006) 295-302
24. Sanders J., Evans M., Betterle C., et al. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking antibody. Thyroid 18 (2008) 735-746
25. Minich W.B., Lenzner C., Bergmann A., and Morgenthaler N.G. A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies. J Clin Endocrinol Metab 89 (2004) 352-356
26. Morgenthaler N.G., Minich W.B., Willnich M., et al. Affinity purification and diagnosis use of TSH receptor autoantibodies from human serum. Mol Cell Endocrinol 212 (2003) 73-79
27. Morgenthaler NG. Clinical utility of human TSH-receptor antibody determination- Is there still doubt? www.hotthyroidology.com, 2008 November HT04/08.